L-Citrulline increases nitric oxide and improves control in obese asthmatics

[1]  E. Bleecker,et al.  Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma. , 2019, American journal of respiratory and critical care medicine.

[2]  M. Maniscalco,et al.  Comparison of three different exhaled nitric oxide analyzers in chronic respiratory disorders , 2019, Journal of breath research.

[3]  R. Gosens,et al.  Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbidities. , 2018, Current opinion in pharmacology.

[4]  K. Ogino,et al.  Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and l-arginine metabolism in mice , 2018, Journal of Physiology and Biochemistry.

[5]  B. Freeman,et al.  l‐citrulline prevents asymmetric dimethylarginine‐mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  M. Palmert,et al.  Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung , 2017, Nutrition & Diabetes.

[7]  Vijay P. Singh,et al.  Metabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs , 2015, PloS one.

[8]  A. Kantar,et al.  Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. , 2013, Chest.

[9]  W. Busse,et al.  An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. , 2013, American journal of respiratory and critical care medicine.

[10]  S. Wenzel,et al.  Reduced L-Arginine/ADMA As A Potential Mechanism To Explain Increased Symptom Severity And Reduced Atopy In Late Onset Obese Asthmatics , 2012, ATS 2012.

[11]  P. Pencharz,et al.  Asymmetric dimethylarginine is increased in asthma. , 2011, American journal of respiratory and critical care medicine.

[12]  A. Linderholm,et al.  l-Arginine Supplementation and Metabolism in Asthma , 2011, Pharmaceuticals.

[13]  J. Celedón,et al.  An official American Thoracic Society Workshop report: obesity and asthma. , 2010, Proceedings of the American Thoracic Society.

[14]  S. Turner,et al.  Changes in exhaled nitric oxide after ingestion of L‐arginine in children: A pilot study , 2010, Pediatric pulmonology.

[15]  T. Ahmad,et al.  Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. , 2010, The Journal of allergy and clinical immunology.

[16]  A. Fitzpatrick,et al.  Obesity, asthma, and oxidative stress. , 2010, Journal of applied physiology.

[17]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[18]  E. R. Sutherland,et al.  Body Mass Index and Response to Asthma Therapy: Fluticasone Propionate/Salmeterol versus Montelukast , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[19]  T. Ahmad,et al.  Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. , 2010, American journal of respiratory cell and molecular biology.

[20]  R. Poulton,et al.  Leptin, adiponectin, and asthma: findings from a population-based cohort study. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  A. Holian,et al.  Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. , 2009, American journal of respiratory cell and molecular biology.

[22]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[23]  D. Mannino,et al.  Body mass index and asthma severity in the National Asthma Survey , 2007, Thorax.

[24]  D. Jung,et al.  Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. , 2008, British journal of clinical pharmacology.

[25]  C. Moinard,et al.  Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study , 2007, British Journal of Nutrition.

[26]  C. Allen,et al.  Effect of obesity on airway inflammation: a cross‐sectional analysis of body mass index and sputum cell counts , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  G. Grimble.  Adverse gastrointestinal effects of arginine and related amino acids. , 2007, The Journal of nutrition.

[28]  A. Holian,et al.  Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. , 2007, American journal of respiratory cell and molecular biology.

[29]  M. Rojas,et al.  Paying attention to neglected diseases. , 2004, Environmental health perspectives.

[30]  S. Willsie.  Influence of body mass index on the response to asthma controller agents , 2007 .

[31]  Raed A Dweik,et al.  Validation Study of Fractional Exhaled Nitric Oxide Measurements Using a Handheld Monitoring Device , 2006, The Journal of asthma : official journal of the Association for the Care of Asthma.

[32]  P. Chanez,et al.  Are overweight asthmatics more difficult to control? , 2005, Allergy.

[33]  B. Morrissey,et al.  L-arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4,342 m. , 2005, High altitude medicine & biology.

[34]  T. Teerlink.  ADMA metabolism and clearance , 2005, Vascular medicine.

[35]  ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. , 2005, American journal of respiratory and critical care medicine.

[36]  H. Arnesen,et al.  Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. , 2004, Metabolism: clinical and experimental.

[37]  S. Morris,et al.  Decreased arginine bioavailability and increased serum arginase activity in asthma. , 2004, American journal of respiratory and critical care medicine.

[38]  S. Wenzel,et al.  Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. , 2004, The Journal of allergy and clinical immunology.

[39]  P. Sterk,et al.  E V ect of oral L -arginine on airway hyperresponsiveness to histamine in asthma , 1999 .

[40]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[41]  M. Hjelm,et al.  L-arginine increases exhaled nitric oxide in normal human subjects. , 1995, Clinical science.

[42]  J. Stamler,et al.  Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. , 1994, The Journal of pharmacology and experimental therapeutics.

[43]  Robert W. Mee,et al.  Regression toward the Mean and the Paired Sample t Test , 1991 .

[44]  J. Hankinson,et al.  Standardization of spirometry--1987 ATS update (American Thoracic Society) , 1988, Journal of occupational medicine. : official publication of the Industrial Medical Association.